Liquid chromatography-tandem mass spectrometric determination of ceramides and related lipid species in cellular extracts
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yoo, Hye Hyun | - |
dc.contributor.author | Son, Junghyun | - |
dc.contributor.author | Kim, Dong-Hyun | - |
dc.date.accessioned | 2021-06-23T21:03:41Z | - |
dc.date.available | 2021-06-23T21:03:41Z | - |
dc.date.created | 2021-01-21 | - |
dc.date.issued | 2006-11 | - |
dc.identifier.issn | 1570-0232 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/44495 | - |
dc.description.abstract | A liquid chromatography-electrospray ionization tandem mass spectrometric (LC-MS/MS) method was developed for the simultaneous qualitative and quantitative determination of sphingolipid metabolites such as ceramides, sphingisine, sphinganine, sphingomyelins, and ceramide 1-phosphates in the extracts of human promyelocytic leukemia cells (HL-60). The assay uses C-4 ceramide as an internal standard; simple liquid extraction; a short XTerra MS C-18 (3 mu m, 50 mm x 2.0 mm) column; a gradient mobile phase of 5 mM ammonium formate (pH 4.0)/methanol/tetrahydrofuran (5/2/3 -> 1/2/7); mass spectrometric detection using electrospray ionization. This LC-MS/MS method allowed the identification of 22 sphingolipid derivatives at pmol levels. In addition, this technique was successfully applied to analyze the changes of the sphingolipids profiles in cancer cells treated with apoptosis inducing agents, C-2 ceramide and H2O2. (c) 2006 Elsevier B.V. All rights reserved. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | Elsevier BV | - |
dc.title | Liquid chromatography-tandem mass spectrometric determination of ceramides and related lipid species in cellular extracts | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Yoo, Hye Hyun | - |
dc.identifier.doi | 10.1016/j.jchromb.2006.06.025 | - |
dc.identifier.scopusid | 2-s2.0-33751018567 | - |
dc.identifier.wosid | 000242361400027 | - |
dc.identifier.bibliographicCitation | Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, v.843, no.2, pp.327 - 333 | - |
dc.relation.isPartOf | Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences | - |
dc.citation.title | Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences | - |
dc.citation.volume | 843 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 327 | - |
dc.citation.endPage | 333 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Biochemical Research Methods | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Analytical | - |
dc.subject.keywordPlus | QUANTITATIVE-DETERMINATION METHOD | - |
dc.subject.keywordPlus | FREE SPHINGOID BASES | - |
dc.subject.keywordPlus | INDUCED APOPTOSIS | - |
dc.subject.keywordPlus | HL-60 CELLS | - |
dc.subject.keywordPlus | DIFFERENTIATION | - |
dc.subject.keywordPlus | QUANTIFICATION | - |
dc.subject.keywordPlus | SPHINGANINE | - |
dc.subject.keywordPlus | RANGE | - |
dc.subject.keywordAuthor | sphingolipid | - |
dc.subject.keywordAuthor | ceramides LC-MS/MS | - |
dc.subject.keywordAuthor | HL-60 cells | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S1570023206005228?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.